Hideko Goto
Overview
Explore the profile of Hideko Goto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goto T, Hatano K, Kanemura N, Makita H, Goto H
J Hematol
. 2024 Dec;
13(6):290-294.
PMID: 39697683
Plasmablastic lymphoma (PBL) is a malignant lymphoma with poor prognosis that occurs in immunocompromised and elderly patients. We describe the case of a 75-year-old woman with PBL as a methotrexate-associated...
2.
Nakamura N, Kanemura N, Matsumoto T, Nakamura H, Ikoma Y, Shibata Y, et al.
Sci Rep
. 2023 Nov;
13(1):19060.
PMID: 37925551
We compared the predictive ability of the International Prognostic Index (IPI), a frequently used prognostic model for peripheral T-cell lymphoma (PTCL), with that of a type-specific prognostic model, the Prognostic...
3.
Nakamura N, Kanemura N, Lee S, Fujita K, Morishita T, Takada E, et al.
Leuk Lymphoma
. 2021 Dec;
63(6):1323-1330.
PMID: 34965828
The controlling nutritional status (CONUT) score is a simplified nutritional index calculated from serum albumin, total cholesterol, and total lymphocyte count. This study evaluated the prognostic impact of the CONUT...
4.
Miwa T, Hatano Y, Kochi T, Aiba M, Toda K, Goto H, et al.
Clin J Gastroenterol
. 2020 May;
13(5):882-890.
PMID: 32472376
Spur cell anemia is an acquired hemolytic anemia associated with liver cirrhosis and is characterized by the presence of increased large red blood cells, which are covered with spike-like projections...
5.
Hara T, Yoshikawa T, Goto H, Sawada M, Yamada T, Fukuno K, et al.
Hematol Oncol
. 2018 Jun;
36(4):638-644.
PMID: 29882279
Pirarubicin (tetrahydropyranyl adriamycin [THP]) is an anthracyclin with less cardiotoxicity than doxorubicin (DOX). We previously reported the efficacy and safety of R-THP-COP consisting of rituximab (R), THP, cyclophosphamide (CPA), vincristine...
6.
Kawakami H, Mochizuki K, Goto H, Watanabe N, Tanaka T
Case Rep Ophthalmol Med
. 2017 May;
2017:8902162.
PMID: 28487798
. To report our findings in a case of orbital T-cell lymphoma in which all of the extraocular muscles (EOMs) were bilaterally and discretely enlarged and the patient had a...
7.
Tanaka O, Oguchi M, Iida T, Kasahara S, Goto H, Takahashi T
Rep Pract Oncol Radiother
. 2016 Sep;
21(6):495-9.
PMID: 27601963
Aim: To determine the efficacy of low-dose palliative radiotherapy in patients with refractory aggressive lymphoma. Background: There are few reports on the administration of palliative radiotherapy to patients with aggressive...
8.
Yasuda M, Tachi T, Umeda M, Nagaya K, Osawa T, Ichihashi A, et al.
Gan To Kagaku Ryoho
. 2016 Jan;
42(13):2447-50.
PMID: 26809302
The onset of thrombocytopenia and related factors was analyzed in patients with multiple myeloma (MM) who were receiving lenalidomide (Len) therapy at the Department of Hematology, Gifu Municipal Hospital between...
9.
Osawa T, Takahashi T, Yasuda M, Umeda M, Nagaya K, Tachi T, et al.
Gan To Kagaku Ryoho
. 2015 May;
42(4):477-9.
PMID: 25963696
Imatinib was administrated to a 38-year-old woman with chronic myeloid leukemia(CML). A major molecular response (MMR)(≤5 copies/0.5 μgRNA in Amp-CML detected using the transcription mediated amplification/hybridization protection assay(TMA/HPA)method)was achieved in...
10.
Yasuda M, Tachi T, Umeda M, Usui K, Nagaya K, Osawa T, et al.
Gan To Kagaku Ryoho
. 2014 Aug;
41(8):975-9.
PMID: 25132029
We investigated factors influencing the occurrence of infusion reactions after initial treatment with rituximab. We included patients who were administered rituximab for the treatment of B-cell non-Hodgkin's lymphoma at the...